The FDA’s Good Plasma Decision

Here we go again. President Trump hypes a Covid-19 therapy that has shown potential based on early studies. The Food and Drug Administration approves the treatment for emergency use and gets lambasted for letting politics influence the science.

This is what occurred with the anti-malaria drug hydroxychloroquine and now is happening with convalescent plasma, which the FDA on Sunday granted “emergency use authorization” (EUA). Mr. Trump was wrong to tweet over the weekend that “the deep state” at the FDA was thwarting development…

Sahred From Source link World News

Be the first to comment

Leave a Reply

Your email address will not be published.